Literature DB >> 12746372

Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review.

Claudia Thomas1, Mark Stevenson, Thomas V Riley.   

Abstract

A systematic review of studies that investigated the association of antibiotics with hospital-acquired Clostridium difficile-associated diarrhoea (CDAD) was undertaken to summarize the strength of the evidence for this relationship. The results from the studies identified were considered after critically reviewing the design and conduct of each study. Although the majority of studies found an association with various antibiotics, antibiotic classes or components of antibiotic administration, most were limited in their ability to establish a causal relationship by the use of incorrect control groups, the presence of bias, inadequate control of confounding and small sample sizes. The limitations identified in this review prevented the pooling of results in a meta-analysis. Two studies of reasonable quality suggested an association between clindamycin, cephalosporins, penicillins and CDAD. Well-designed studies grounded in epidemiological principles are needed to identify true risk factors for CDAD and to provide reliable estimates of the strength of association.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746372     DOI: 10.1093/jac/dkg254

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  66 in total

1.  The effect of statins on the outcome of Clostridium difficile infection in hospitalized patients.

Authors:  A Atamna; D Yahav; N Eliakim-Raz; E Goldberg; H Ben-Zvi; A Barsheshet; A Elis; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-10       Impact factor: 3.267

2.  Binary toxin and its clinical importance in Clostridium difficile infection, Belgium.

Authors:  T Pilate; J Verhaegen; M Van Ranst; V Saegeman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-08       Impact factor: 3.267

Review 3.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 4.  Clostridium difficile associated diarrhoea: diagnosis and treatment.

Authors:  John Starr
Journal:  BMJ       Date:  2005-09-03

5.  Community-acquired pneumonia: doctors do not follow national guidelines.

Authors:  Paul Collini; Mike Beadsworth; Jim Anson; Tim Neal; Peter Burnham; Paul Deegan; Nick Beeching; Alastair Miller
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

6.  Predictors of Clostridium difficile colitis infections in hospitals.

Authors:  R Ricciardi; K Harriman; N N Baxter; L K Hartman; R J Town; B A Virnig
Journal:  Epidemiol Infect       Date:  2007-08-09       Impact factor: 2.451

7.  Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients.

Authors:  Mamoon A Aldeyab; Stephan Harbarth; Nathalie Vernaz; Mary P Kearney; Michael G Scott; Chris Funston; Karen Savage; Denise Kelly; Motasem A Aldiab; James C McElnay
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

Review 8.  Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.

Authors:  Orna Nitzan; Mazen Elias; Bibiana Chazan; Raul Raz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

9.  Decreasing Clostridium difficile infections by an antimicrobial stewardship program that reduces moxifloxacin use.

Authors:  Judith Maria Wenisch; Susanne Equiluz-Bruck; Marta Fudel; Ingun Reiter; Andrea Schmid; Erna Singer; Andreas Chott
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

10.  Clostridium difficile in urology.

Authors:  M Hossain; T J Crook; S R Keoghane
Journal:  Ann R Coll Surg Engl       Date:  2008-01       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.